Status:
TERMINATED
Treatment of Anemia and Neutropenia in HIV/HCV Coinfected Patients Treated With Pegylated Interferon and Ribavirin
Lead Sponsor:
Weill Medical College of Cornell University
Collaborating Sponsors:
Schering-Plough
Conditions:
Anemia
Neutropenia
Eligibility:
All Genders
18-70 years
Phase:
PHASE4
Brief Summary
This study is designed to test two separate strategies for treatment of anemia (low hemoglobin) and neutropenia (low white blood cells) in HIV/HCV coinfected patients who are being treated with pegyla...
Detailed Description
This is a multi-center, randomized, open-labeled trial in subjects co-infected with hepatitis C (HCV) and human immunodeficiency virus type 1 (HIV-1) who are naïve to anti-HCV therapy. Subjects will r...
Eligibility Criteria
Inclusion
- hemoglobin \> 11
- absolute neutrophil count \>1,200
- naive to peg interferon and ribavirin
Exclusion
- Prior treatment for hepatitis C
- Pregnant or nursing
Key Trial Info
Start Date :
February 1 2002
Trial Type :
INTERVENTIONAL
End Date :
December 1 2005
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00194857
Start Date
February 1 2002
End Date
December 1 2005
Last Update
December 17 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Weill Medical College of Cornell University
New York, New York, United States, 10021